Hepatitis B Core IgM

Understanding the Hepatitis B Core Antibody IgM blood test

The Hepatitis B Core Antibody IgM blood test measures IgM antibodies directed against the core antigen of the Hepatitis B virus. These antibodies are produced during the early phase of infection and are a key marker of acute or recent Hepatitis B infection.

Unlike other Hepatitis B markers, the core antibody is not produced following vaccination. This makes the Hepatitis B Core Antibody IgM test particularly valuable for distinguishing true infection from vaccine-related immunity. It is also crucial in identifying the “window period,” a stage when surface antigen and surface antibodies may be temporarily undetectable.

This test is commonly used as part of a broader Hepatitis B panel to determine infection stage, guide clinical management, and assess potential infectivity.

When testing for Hepatitis B Core Antibody IgM is clinically important

This test is recommended when there is suspicion of recent Hepatitis B infection, abnormal liver blood results, or symptoms consistent with viral hepatitis. It plays a critical role in differentiating acute infection from chronic disease or resolved past infection.

Hepatitis B can present with a wide range of symptoms, from mild and non-specific to severe liver inflammation. In some individuals, symptoms may be minimal or absent, making blood testing essential for accurate diagnosis.

Testing may be appropriate if you experience:

• Unexplained fatigue or weakness
• Jaundice (yellowing of the skin or eyes)
• Dark urine or pale stools
• Nausea, vomiting, or loss of appetite
• Upper right abdominal discomfort
• Recently abnormal liver function tests
• Possible exposure through blood or sexual contact
• Occupational exposure to blood or body fluids

Key benefits of the Hepatitis B Core Antibody IgM test

1. Identifies acute or recent Hepatitis B infection
   Confirms early immune response to active infection.
2. Not affected by vaccination status
   Distinguishes true infection from vaccine immunity.
3. Detects infection during the window period
   Identifies cases missed by other Hepatitis B markers.
4. Supports accurate staging of Hepatitis B
   Helps differentiate acute from chronic infection.
5. Guides appropriate clinical follow-up
   Supports decisions on monitoring and referral.
6. Clarifies unexplained liver abnormalities
   Useful when liver enzymes are raised.
7. Simple blood test with no preparation required
   No fasting or lifestyle changes needed.
8. Provides reassurance through clear diagnosis
   Reduces uncertainty following potential exposure.

How the test is carried out

We offer two convenient UK-wide testing options:

Clinic-based blood testing

• Choose your nearest UK clinic
• A healthcare professional collects a blood sample
• The sample is analysed in a certified laboratory
• Results are issued once testing is complete

Home or hotel blood collection (+£60)

• A qualified phlebotomist visits your home, workplace, or hotel
• Blood is collected at a time convenient for you
• No need to travel or attend a clinic
• Available nationwide across the UK

Both options provide the same laboratory accuracy and clinical reliability.

Understanding your Hepatitis B Core Antibody IgM results

Low levels (Negative result)

Low or undetectable Hepatitis B Core Antibody IgM levels indicate no evidence of recent or acute infection. This may suggest no infection, resolved past infection, or immunity due to vaccination.

Typical UK reference range:

• Negative: Non-reactive

Further testing may be advised depending on other Hepatitis B markers.

Borderline levels (Equivocal result)

Borderline results indicate antibody levels that are not clearly negative or positive. This may occur very early in infection or during immune transition.

Typical UK reference range:

• Equivocal: Borderline / Indeterminate

Repeat testing or additional Hepatitis B markers are usually recommended.

High levels (Positive result)

Elevated Hepatitis B Core Antibody IgM levels indicate acute or recent Hepatitis B infection. This result is strongly associated with active viral infection and requires clinical follow-up.

Typical UK reference range:

• Positive: Reactive

Further Hepatitis B testing is typically advised to assess infectivity and liver health.